Indicine N-oxide

Suppliers

Names

[ CAS No. ]:
41708-76-3

[ Name ]:
Indicine N-oxide

[Synonym ]:
Indicine N-oxide

Chemical & Physical Properties

[ Molecular Formula ]:
C15H25NO6

[ Molecular Weight ]:
315.36200

[ Exact Mass ]:
315.16800

[ PSA ]:
116.42000

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
EK7791200
CHEMICAL NAME :
Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H- pyrrolizin-7-yl)methyl ester, N-oxide, (1R-(1-apha,7(2R*,3S),7-a lpha,beta))-
CAS REGISTRY NUMBER :
41708-76-3
LAST UPDATED :
199612
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C15-H25-N-O6

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1917 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3733 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - respiratory depression Skin and Appendages - hair
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: PB84-161694
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
GVRAAS Government Reports Announcements. (U.S.) (Washington, D.C.) V.71(6) -75(6), 1971-75. Merged with Government Reports Index (US) to form Government Reports Announcement Index (U.S.) Volume(issue)/page/year: 74(9),60,1974 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
24 gm/kg/4W-I
TOXIC EFFECTS :
Blood - macrocytosis Related to Chronic Data - death
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 101,271,1989
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1350 mg/kg/9D-I
TOXIC EFFECTS :
Blood - macrocytosis Related to Chronic Data - death
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 101,271,1989

Safety Information

[ RIDADR ]:
UN 1544

[ Packaging Group ]:
III

[ Hazard Class ]:
6.1(b)

Synthetic Route

Precursor & DownStream

Precursor

  • Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, (1R-(1a,7(2R*,3S*),7a-beta))-
  • (1'S,2S,5R)-2-(t-butyl)-5-(1'hydroxyethyl)-5-isopropyl-1,3-dioxolan-4-one
  • Retronecine

DownStream


Related Compounds

  • Indicine N-oxide
  • Indicine N-oxide
  • (-)-indicine N-oxide
  • Camptothecin N-oxide
  • (1S,5R,13R,17S)-17-Hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one 4-oxide
  • Azithromycin N-Oxide
  • N-[(5-methylthiophen-2-yl)methyl]hydroxylamine
  • N-[(4-bromothiophen-2-yl)methyl]hydroxylamine
  • 1-(2-Hydroxyethyl)-2-methylpyrrole-3-carboxylic acid
  • n-[(5-Bromofuran-2-yl)methyl]hydroxylamine
  • N-[(1-methyl-1H-pyrazol-4-yl)methyl]hydroxylamine
  • N-[(2-methyl-1,3-thiazol-5-yl)methyl]hydroxylamine
  • N-{[2-(propan-2-yloxy)phenyl]methyl}hydroxylamine
  • N-[(quinoxalin-2-yl)methyl]hydroxylamine
  • N-[(oxolan-3-yl)methyl]hydroxylamine
  • N-[(2-bromo-4-methylphenyl)methyl]hydroxylamine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.